| 2004N-0115 - Prescription Drug Importation; Public Meeting | |||||||||||||||||||||||
| FDA Comment Number : | EC54 | ||||||||||||||||||||||
| Submitter : | Dr. Jeffrey Greenberg | Date & Time: | 06/02/2004 09:06:42 | ||||||||||||||||||||
| Organization : | Dr. Jeffrey Greenberg | ||||||||||||||||||||||
| Health Professional | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| Given the choice, consumers will purchase the lower cost imported drugs. There will likely be safety and purity issues. Assuring the safety and purity of all imported drugs will be an extremely costly endeavor. Who will bear the cost of this regulation? | |||||||||||||||||||||||